| | | | | |
| $44,7600 | -1,41% | $292,68M | $15,41K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0550 | -0,05% | $292,61M | $6,54K | |
NUCL Eagle Nuclear Energy Corp. Common stock | $9,6160 | -2,77% | $292,53M | $109,85K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4100 | +0,10% | $292,20M | $230,00 | |
FWDI Forward Industries, Inc. Common Stock | $4,1750 | +5,43% | $292,06M | $775,61K | |
ELDN Eledon Pharmaceuticals, Inc. Common Stock | $3,8640 | +2,22% | $291,76M | $1,22M | |
| $9,6600 | -2,52% | $291,70M | $884,78K | |
SVAQ Silicon Valley Acquisition Corp. Class A Ordinary Shares | $10,0800 | -0,10% | $291,56M | $6,14K | |
WNEB Western New England Bancorp, Inc. | $14,3410 | -0,96% | $291,41M | $14,52K | |
| $8,0000 | -4,19% | $291,40M | $88,81K | |
PACH Pioneer Acquisition I Corp Class A Ordinary Shares | $10,2400 | +0,00% | $291,22M | $13,00 | |
MMD NYLI MacKay DefinedTerm Muni Opportunities Fund | $15,5090 | +0,06% | $291,08M | $38,37K | |
AENT Alliance Entertainment Holding Corporation Class A Common Stock | $5,9050 | +3,42% | $291,06M | $6,66K | |
GLSI Greenwich LifeSciences, Inc. | $22,6870 | +14,58% | $290,62M | $124,53K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,9750 | +4,61% | $290,56M | $284,86K | |
